172 related articles for article (PubMed ID: 2558989)
21. Primary tumour characteristics and axillary lymph node status in breast cancer.
Yiangou C; Shousha S; Sinnett HD
Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions.
Cody HS
J Surg Oncol; 2007 May; 95(6):440-2. PubMed ID: 17458860
[No Abstract] [Full Text] [Related]
24. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
25. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
26. Video-assisted axillary surgery for cancer: non-randomized comparison with conventional techniques.
Hussein O; El-Nahhas W; El-Saed A; Denewer A
Breast; 2007 Oct; 16(5):513-9. PubMed ID: 17532217
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
28. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
29. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
Fisher B; Wolmark N; Bauer M; Redmond C; Gebhardt M
Surg Gynecol Obstet; 1981 Jun; 152(6):765-72. PubMed ID: 7244951
[No Abstract] [Full Text] [Related]
30. Occult axillary lymph node metastases discovered by serial section in node-negative breast cancer.
Karalak A; Homcha-Em P
J Med Assoc Thai; 1999 Oct; 82(10):1017-9. PubMed ID: 10561965
[TBL] [Abstract][Full Text] [Related]
31. [The axillary lymph nodes in breast carcinoma].
Huhn FO
Geburtshilfe Frauenheilkd; 1966 Feb; 26(2):164-79. PubMed ID: 4293052
[No Abstract] [Full Text] [Related]
32. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
33. [Tumor markers for differentiating between sinus histiocytosis and minimal axillary lymph node metastasis in lobular invasive carcinoma].
Tschahargane C; Born A; Anton HW; Breuner I
Verh Dtsch Ges Pathol; 1985; 69():327-30. PubMed ID: 3913201
[No Abstract] [Full Text] [Related]
34. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
35. Intraoperative imprint cytology of sentinel nodes in breast cancer.
Barranger E; Antoine M; Grahek D; Callard P; Uzan S
J Surg Oncol; 2004 Jun; 86(3):128-33. PubMed ID: 15170650
[TBL] [Abstract][Full Text] [Related]
36. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
[TBL] [Abstract][Full Text] [Related]
37. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
38. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
39. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
40. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.
Man YG; Schwartz A; Levine PH; Teal C; Berg PE
Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
